- Home
- VINP vs HUMA Comparison
VINP vs HUMA Comparison
Compare VINP & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- HUMA
- Stock Information
- Founded
- VINP 2009
- HUMA 2004
- Country
- VINP Brazil
- HUMA United States
- Employees
- VINP N/A
- HUMA N/A
- Industry
- VINP Investment Managers
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- VINP Finance
- HUMA Health Care
- Exchange
- VINP Nasdaq
- HUMA Nasdaq
- Market Cap
- VINP 641.7M
- HUMA 584.8M
- IPO Year
- VINP 2021
- HUMA N/A
- Fundamental
- Price
- VINP $10.27
- HUMA $4.37
- Analyst Decision
- VINP Strong Buy
- HUMA Strong Buy
- Analyst Count
- VINP 2
- HUMA 7
- Target Price
- VINP $13.50
- HUMA $13.43
- AVG Volume (30 Days)
- VINP 62.7K
- HUMA 2.4M
- Earning Date
- VINP 02-26-2025
- HUMA 03-21-2025
- Dividend Yield
- VINP 6.75%
- HUMA N/A
- EPS Growth
- VINP N/A
- HUMA N/A
- EPS
- VINP 0.60
- HUMA N/A
- Revenue
- VINP $88,217,697.00
- HUMA N/A
- Revenue This Year
- VINP $17.23
- HUMA N/A
- Revenue Next Year
- VINP $51.06
- HUMA $4,344.68
- P/E Ratio
- VINP $17.33
- HUMA N/A
- Revenue Growth
- VINP 9.03
- HUMA N/A
- 52 Week Low
- VINP $9.01
- HUMA $2.81
- 52 Week High
- VINP $11.85
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- VINP 56.01
- HUMA 45.11
- Support Level
- VINP $10.00
- HUMA $4.20
- Resistance Level
- VINP $10.49
- HUMA $4.78
- Average True Range (ATR)
- VINP 0.22
- HUMA 0.28
- MACD
- VINP 0.07
- HUMA -0.02
- Stochastic Oscillator
- VINP 72.73
- HUMA 42.17
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.